[The second life of daptomycin: analysis of a successful come-back].
Decousser
J-W
JW
Doucet Populaire
F
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017576:Daptomycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004358:Drug Therapy / Q000639:trends; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D016106:Methicillin Resistance; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D009135:Muscular Diseases / Q000139:chemically induced; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D017576:Daptomycin